5-amino-1mq weight loss study 5 amino 1mq nnmt inhibitor

Endocrine Research

Beyond weight loss, early exploratory data suggest potential benefits including: Reductions in HbA1c (a marker of blood sugar control) in people with type 2 diabetes Improvements in lipid profiles (cholesterol and triglycerides) Reductions in liver fat, which may be relevant for metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), though these findings are preliminary Possible cardiovascular benefits

Compounding pharmacies, regulated by the FDA and state boards, create personalized formulations under stringent quality controls, ensuring purity, accurate dosing, and sterilityreducing risks of contamination or substandard products.[41][42][43] These are tailored for human use under medical supervision, often with third-party testing

Triglycerides values were not included for analysis since the measurements were confounded by sample hemolysis that interfered with the triglyceride reagent in the assay